Can a High-Tech wearable steady the steps of nerve damage patients?

NCT ID NCT07236515

Recruiting now Disease control Sponsor: MYNERVA AG Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times

Summary

This study tests a wearable device called the Leia sensory prosthesis in 80 adults with peripheral neuropathy, a condition that often causes balance problems and unsteady walking. Participants will either use the active device or a sham version for two months. The main goal is to see if the device improves gait and balance, as measured by a standard walking test.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: wearable sensory prosthesis device
What this could lead to: If it works, this could provide a non-invasive way to help people with peripheral neuropathy walk more steadily and reduce fall risk.
What could go wrong: This is an early-stage trial with only 80 participants, and the device is compared to a sham version, so the real benefit may be small or absent. It also requires regular clinic visits and home use, which may not suit everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL NEUROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

peripheral nervous system disorder peripheral neuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERIPHERAL NEUROPATHY

Contacts and locations

Locations

Ensemble Hospitalier de la Côte (EHC)
RECRUITING

Morges, 1110, Switzerland
Hôpital de la Tour
NOT_YET_RECRUITING

Meyrin, 1217, Switzerland
Universitätsklinik Balgrist
NOT_YET_RECRUITING

Zurich, 8008, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.